IMDQ Pep-LNP
Cat. No.: TDLD-0126-LD105
IMDQ Pep-LNP
IMDQ Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered with IMDQ Peptide, designed for targeted drug delivery by enhancing solubility, stability, and bioavailability, with reduced immunogenicity and improved therapeutic efficacy through targeted activation. Applications include targeted therapeutic development and biological research. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | IMDQ Peptide |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
Targeted CD34 Ab-LNP (TDLD-0825-LD68)
CD19 CAR mRNA-LNP (TDLD-0825-LD48)
GGSPYGRC Pep-LNP (TDLD-0126-LD91)
MSLN CAR mRNA-LNP (TDLD-0825-LD42)
PSMA CAR mRNA-LNP (TDLD-0825-LD51)
CAQK Pep-LNP (TDLD-0126-LD154)
Cy5-labeled Fluc mRNA-LNP (TDLD-0825-LD23)
AXL CAR mRNA-LNP (TDLD-0825-LD56)
Online Inquiry
